3 results match your criteria: "Kashi Center for Disease Control and Prevention[Affiliation]"

Emergence of an ancient and pathogenic mammarenavirus.

Emerg Microbes Infect

December 2023

State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Article Synopsis
  • Emerging zoonoses from wildlife, like the plateau pika virus (PPV), pose significant threats to human health, especially in unique ecosystems like the Qinghai-Tibet Plateau.
  • Researchers identified PPV through virome analysis and found that it can replicate in various mammalian cells, causing serious health issues in animal models, including trembling and sudden death.
  • PPV is distinct from other known mammarenaviruses, with an estimated divergence time of 77-88 million years, indicating its long-standing presence before other similar viruses.
View Article and Find Full Text PDF

A Tuberculosis Outbreak During the COVID-19 Pandemic - Hubei Province, China, 2020.

China CDC Wkly

June 2021

State Key Laboratory of Virology, School of Health Sciences, Wuhan University, Wuhan, Hubei, China.

Multidrug-resistant tuberculosis (MDR-TB) has become a growing threat to public health. There were few reports about family-to-school MDR-TB outbreaks in China, especially during the coronavirus disease 2019 (COVID-19) pandemic. A tuberculosis (TB) outbreak happened in Hubei Province during the COVID-19 pandemic.

View Article and Find Full Text PDF

Background: The prevalence of drug-resistant tuberculosis (TB) in Xinjiang is higher than in other regions of China, and Beijing/W lineage Mycobacterium tuberculosis (MTB) is the dominant strain of MTB in Xinjiang. However, information on multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, particularly the correlation between MDR and the Beijing/W lineage and the correlation between drug resistance and the Beijing/W sublineage strains, is limited.

Material/methods: We conducted a prospective study to describe the prevalence of MDR/XDR TB, Beijing/W lineage and sublineage strains in Xinjiang in China from 2009 to 2013.

View Article and Find Full Text PDF